Abstract:Pulmonary arterial hypertension (PAH) is characterized by persistently elevated pulmonary artery pressure and vascular resistance. Sympathetic overactivity in hypertension participates in pulmonary vascular remodeling and heart failure. The present study aims to explore the efficacy of highly selective thoracic sympathectomy (HSTS) on lowering pulmonary artery pressure, reversing pulmonary vascular remodeling, and improving right ventricular function in rats. A total of 24 Sprague-Dawley rats were randomly assigned into the control group ( n = 8) and experimental group ( n = 16). Rats in the control group were intraperitoneally injected with 0.9% normal saline, and those in the experimental group were similarly administered with received monocrotaline (MCT) injections at 60 mg/kg. Two weeks later, rats in the experimental group were further subdivided randomly into the MCT-HSTS group ( n = 8) and MCT-sham group ( n = 8), and they were surgically treated with HSTS and sham operation, respectively. Two weeks later, significantly lowered mean pulmonary artery pressure (mPAP), pulmonary artery systolic pressure (sPAP), and the ratio of sPAP to femoral artery systolic pressure (sFAP) were detected in the MCT-HSTS group than those of the MCT-sham group. In addition, rats in the MCT-HSTS group presented a significantly lower ratio of vascular wall area to the total vascular area (WT%), right ventricular hypertrophy index, and degrees of right ventricular fibrosis and lung fibrosis in comparison to those of the MCT-sham group. HSTS significantly downregulated protein levels of inflammasomes in pulmonary artery smooth muscle cells (PASMCs). Collectively, HSTS effectively reduces pulmonary artery pressure, pulmonary arteriolar media hypertrophy, and right ventricular hypertrophy in MCT-induced PAH rats. It also exerts an anti-inflammatory effect on PASMCs in PAH rats by suppressing inflammasomes and the subsequent release of inflammatory cytokines.

Changes in the gut microbiome and metabolome in a rat model of pulmonary arterial hypertension

Systemic Evaluation of Platelet and Leukocyte Activation and Interaction in A Rat Model of Pulmonary Arterial Hypertension

[The Change of Mast Cells and Macrophages in the Lung of Rat with Pulmonary Hypertension].

Gut Fungal Microbiota Alterations in Pulmonary Arterial Hypertensive Rats

Disease-associated gut microbiome and metabolome changes in rats with chronic hypoxia-induced pulmonary hypertension

Pulmonary arterial hypertension-associated changes in gut pathology and microbiota

Quantitative Proteomic and Phosphoproteomic Profiling of Lung Tissues from Pulmonary Arterial Hypertension Rat Model

Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline

Expression of key enzymes in the mevalonate pathway are altered in monocrotaline-induced pulmonary arterial hypertension in rats

Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertension

High-circulating Gut Microbiota-Dependent Metabolite Trimethylamine N-oxide is Associated with Poor Prognosis in Pulmonary Arterial Hypertension.

The Role and Mechanism of Gut Microbiota in Pulmonary Arterial Hypertension

Causal impact of gut microbiota and associated metabolites on pulmonary arterial hypertension: a bidirectional Mendelian randomization study

Changes of gut microbiome composition and metabolites associated with hypertensive heart failure rats

Role of Gut Microbiota in Pulmonary Arterial Hypertension

Changes in expression of hepatocyte growth factor and c-met in lungs in a rat model of pulmonary hypertension

The Impact of Highly Selective Thoracic Sympathectomy on the Progression of Monocrotaline-induced Pulmonary Arterial Hypertension in Rats

Activation of Peroxisome Proliferator-Activated Receptor Γ Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

Inhibition of Ubiquitin Proteasome Function Prevents Monocrotaline-Induced Pulmonary Arterial Remodeling

Differential Expression of Microrna in the Lungs of Rats with Pulmonary Arterial Hypertension

Activation of AMPK Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension by Suppression of NF-κB-mediated Autophagy Activation.